Quantum BioPharma Ltd.
QNTM
$9.70
-$1.71-14.99%
NASDAQ
| 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | |
|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -- | -- | -- | -- | -- |
| Cost of Revenue | -- | -- | -- | -- | -- |
| Gross Profit | -- | -- | -- | -- | -- |
| SG&A Expenses | 4.04M | 4.16M | 1.62M | 1.85M | 3.32M |
| Depreciation & Amortization | 145.30K | 141.40K | 129.70K | 112.80K | 120.80K |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 4.68M | 4.85M | 3.40M | 6.24M | 4.18M |
| Operating Income | -4.68M | -4.85M | -3.40M | -6.24M | -4.18M |
| Income Before Tax | -4.75M | -9.77M | -8.74M | -5.46M | -4.02M |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -4.75M | -9.77M | -8.74M | -5.46M | -4.02M |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -571.40K | 513.30K | 163.20K | 96.00K | 188.20K |
| Net Income | -5.32M | -9.25M | -8.58M | -5.36M | -3.83M |
| EBIT | -4.68M | -4.85M | -3.40M | -6.24M | -4.18M |
| EBITDA | -4.53M | -4.71M | -3.27M | -6.13M | -4.06M |
| EPS Basic | -1.40 | -3.06 | -3.47 | -2.70 | -4.17 |
| Normalized Basic EPS | -0.96 | -1.83 | -2.19 | -1.90 | -2.54 |
| EPS Diluted | -1.40 | -3.06 | -3.47 | -2.70 | -4.17 |
| Normalized Diluted EPS | -0.96 | -1.83 | -2.19 | -1.90 | -2.54 |
| Average Basic Shares Outstanding | 3.80M | 3.02M | 2.48M | 1.98M | 917.80K |
| Average Diluted Shares Outstanding | 3.80M | 3.02M | 2.48M | 1.98M | 917.80K |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |